Pay in installments of $5.31 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Talking Back to RitalinMillions of children take Ritalin for Attention Deficit Hyperactivity Disorder. The drug's manufacturer, Novartis, claims that Ritalin is the "solution" to this widespread problem. But hidden behind the well oiled public relations machine is a potentially devastating reality: children are being given a drug that can cause the same bad effects as amphetamine and cocaine, including behavioral disorders, growth suppression, neurological tics, agitation,
Millions of children take Ritalin for Attention-Deficit Hyperactivity Disorder. The drug's manufacturer, Novartis, claims that Ritalin is the "solution" to this widespread problem. But hidden behind the well-oiled public-relations machine is a potentially devastating reality: children are being given a drug that can cause the same bad effects as amphetamine and cocaine, including behavioral disorders, growth suppression, neurological tics, agitation, addiction, and psychosis. Talking Back to Ritalin uncovers these and other startling facts and translates the research findings for parents and doctors alike. An advocate for education not medication, Dr. Breggin empowers parents to channel distracted, disenchanted, and energetic children into powerful, confident, and brilliant members of the family and society.Binding Type: Paperback
Publisher: Da Capo Press
Published: 09/17/2001
ISBN: 9780738205441
Pages: 448
Weight: 1.48lbs
Size: 8.98h x 6.02w x 1.15d
Review Citations: Choice 02/01/2002 pg. 1075
Scitech Book News 12/01/2001 pg. 123
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.9 ★★★★★
Based on 9 reviews
Sort
Product Reviews
★★★★★ 5
Great size
Size: 21 Inch by 37 Inch
What a great pillow, finally one that fits inside my oversized king bed shams perfectly, filled it out fully, fluffy but full, has good support, not a soft or a hard pillow just really full all the way to the corners, made very well good quality, but this would actually be a good bed pillow but for me its for my shams & I couldn't be more pleased, highly recommend.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 12, 2025
★★★★★ 5
Lovely pillow …
Size: 14 Inch by 14 Inch
This pillow has the perfect softness for easing into your couch or chair. This pillow is so soft and comfortable.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 20, 2026
★★★★★ 5
Great product !
Size: 11 Inch by 11 Inch
Accurate dimensions and fit inside the pillow case perfectly.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 16, 2026
★★★★★ 4
Revised review
Size: 20 Inch by 26 Inch
I have ordered many of these pillows and loved them! Nice and squishy but didn’t flatten like down pillows. I needed a bunch for Airbnb but they are very pricey. Was reading the reviews and several said that the pillows had changed. I thought, how much could they have changed? So I went ahead with purchase. I felt like I may as well have gone to Walmart and bought a cheap foam pillow.
Update: finally tried the pillow myself. Although there is a definite difference, it is very soft and fluffy. Changed my rating from 2 to 4 stars.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2025
★★★★★ 5
Great insert.
Size: 15 Inch by 15 Inch
Great pillow insert.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 2, 2026